Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum PsyBio Therapeutics V.PSYB

Alternate Symbol(s):  PSYBF

PsyBio Therapeutics Corp is a biotechnology company. The company is engaged in the development of drugs intended for the treatment of mental illness and neurological disorders.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

$nirv.cn new video

https://youtu.be/GBP6u9ZEVtA  rate and reply

Meltdown?

Wow, just checking back on PSYB to see if there's anything new, and nadda. What happened to their website, and the people that were part of the research, development, and regulatory teams? What...read more

News

PsyBio Therapeutics Announces Proposed Acquisition of Everest Pharma (Pty) Ltd., a Lesotho Company in Southern Africa, as Part of Its Ongoing Impact Investment Strategy well i have no clue what to...read more

RE:$ORIG to ipo super soon!

With the psychedelics industry currently resting at all time lows, now probably isn't the best time for Origin to hit the market. But the positive side of this is that Origin has a great...read more

$ORIG to ipo super soon!

The more I read about Origin Therapeutics the more excited I am for them to go public. Through a portfolio including both private and public companies, it’s going to give retail investors a great...read more

Still awaiting $ORIG ipo date- but that may be a good thing

As the end of Q4 draws nearer by the hour, it appears we won’t be getting a clear IPO date from Origin therapeutics. However, as the psychedelic market continues to see all-time lows, I don’t think...read more

RE:$ORIG- to IPO soon

Origin Therapeutics is still expected to go public before the end of Q4, giving retail investors an opportunity to invest in the private sector of the psychedelics market.    With...read more

$ORIG- to IPO soon

The therapeutic psychedelic industry is expected to grow at a CAGR of 16.3% to reach a market value of $10.75 billion by 2027. The rapidly increasing acceptance of psychedelic treatments is creating a...read more

$ORIG worth keeping an eye on

With public acceptance of therapeutic psychedelics increasing, there are a few companies on my radar to watch in the immediate future. With business publications starting to hop on the trend now, it’s...read more

RE:RE:RE:Holding Pretty Good

Hey BW, bad news. Jumped back in, and regretted it. Tax loss Season, so I sold out the other week. I see most of the co's in this sector have been in decline. Hope you've been having better...read more

$ORIG Investee TripSitter Trading on CSE

Origin Therapeutics’ (soon to IPO under the ticker $ORIG) portfolio company TripSitter commenced trading on the CSE late November.  Tripsitter has seen tremendous growth in the past year, and...read more

Furthers Intellectual Property Portfolio

Intellectual Property Filing and Protection Remains a Top Priority OXFORD, Ohio and COCONUT CREEK, Fla., Nov. 19, 2021  /CNW/ - PsyBio Therapeutics Corp. (TSXV: PSYB...read more

COMPASS Pathways announces positive topline results

big boost for the business model of Psybio! https://ceo.ca/@nasdaq/compass-pathways-announces-positive-topline-results  rate and reply

Filing of Final Base Shelf Prospectus

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA/ OXFORD, Ohio and COCONUT CREEK, Fla., Nov. 1, 2021 /CNW/ - ...read more

RE:RE:Holding Pretty Good

Sorry for delayed reply PS... I'd forgottent about PSYB until today. It looks like you made the right call. They've fallen off everyone's radar. Not sure what kind of catalyst will get it...read more

RE:Successfully Demonstrates Commercial Scale Manufacturing

seems this is still completely off the radar of th market. great news flow with significant progress being made according to the forecasts. patience is the game here...  rate and reply

Successfully Demonstrates Commercial Scale Manufacturing

PsyBio is one of the only biotechnology companies in the psychedelic industry with the ability to manufacture therapeutics at commercial scale OXFORD, Ohio and COCONUT CREEK, Fla., ...read more

Pre-IND Application Request Has Been Submitted to FDA

OXFORD, Ohio and COCONUT CREEK, Fla., Sept. 23, 2021 /CNW/ - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), an...read more

WHAT THE MINIMUM PRICE TO GO ON NYSE

eom  rate and reply

VERY GOOD NEWS

  Psybio Therapeutics added to AdvisorShares Psychedelics   2021-09-17 09:25 ET - News Release   Mr. Evan Levine reports PSYBIO THERAPEUTICS ANNOUNCES INCLUSION IN NYSE...read more